Treatment of glioma cells with TMZ causes upregulation of CHAC1 expression, which is in turn correlated with enhanced apoptotic cell death via caspase 3/9 activation (Chen et al., 2017). This evidence concerns the gene CASP3 and central nervous system cancer.